Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Annexon, Inc. Common Stock

ANNX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ANNX by members of U.S. Congress

ANNX Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ANNX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ANNX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ANNX holdings by institutional investors

Quarterly net insider trading by ANNX's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $50,000 Jul 18, 2025 Issue: Health Issues
  • $10,000 Jul 16, 2025 Issue: Health Issues

Former government officials who have lobbied for ANNX

1 former government official from 1 congressional office at 1 lobbying firm has lobbied for ANNX, most recently Jul 18, 2025.

  • Orrin G. Hatch
    Patricia Deloatche Senate Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, Legislative Assistant, Rep. Mike Bilirakis Formerly with Orrin G. Hatch · SIDLEY AUSTIN LLP · Jul 18, 2025

ANNX Estimated quarterly lobbying spending

ANNX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ANNX Income Statement
ANNX Balance Sheet
ANNX Cash Flow
U.S. Patents

New ANNX patent grants

  • Patent Title: Method of treating a blood disorder associated with c1q-mediated activation of the classical complement pathway by administering an anti-c1q antibody Sep. 15, 2026
  • Patent Title: Inhibitors of complement factors and uses thereof Jan. 13, 2026
  • Patent Title: Inhibitors of complement factors and uses thereof Dec. 30, 2025
  • Patent Title: Anti-complement factor c1q antibodies with single binding arms and uses thereof Dec. 02, 2025
  • Patent Title: Anti-complement factor c1q fab fragments and uses thereof Jun. 04, 2024
  • Patent Title: Inhibitors of complement factors and uses thereof Nov. 14, 2023
  • Patent Title: Anti-complement factor c1q antibodies and uses thereof May. 16, 2023
  • Patent Title: Anti-complement factor c1q antibodies and uses thereof Feb. 23, 2021
  • Patent Title: Anti-complement factor c1q fab fragments and uses thereof Jul. 28, 2020
  • Patent Title: Anti-complement factor c1q antibodies and uses thereof Mar. 17, 2020
  • Patent Title: Humanized anti-complement factor c1q antibodies Jun. 11, 2019
  • Patent Title: Anti-complement factor c1q antibodies and uses thereof Mar. 12, 2019
  • Patent Title: Anti-complement factor c1q antibodies and uses thereof Jul. 18, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ANNX from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ANNX News

Recent insights relating to ANNX

CNBC Recommendations

Recent picks made for ANNX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ANNX

ANNX Analyst Ratings

ANNX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ANNX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ANNX stock a Buy, Sell, or Hold?

  • What is the price target for $ANNX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ANNX Top Shareholders
Shareholder
Shares Held
ANNX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ANNX stock?

  • Who owns the most shares of $ANNX stock?

  • What funds own $ANNX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ANNX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ANNX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ANNX

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

  • Address Brisbane, CA
  • Market Cap 720.4 million
  • Employees 92
  • Industrial Classification Pharmaceutical Preparations

Annexon, Inc. Common Stock (ANNX) Historical Stock Prices

Annexon, Inc. Common Stock (ANNX) closed at $3.80 on September 24, 2026. Over the past year its adjusted close ranged from $2.68 to $6.96. Daily prices go back to July 24, 2020, 1,550 trading days in all.

  • 1 month-26.21%
  • 3 months-26.21%
  • Year to date-24.30%
  • 1 year+34.75%
  • 3 years+52.61%
  • 5 years-81.86%
  • Max-78.60%
See every congressional and insider trade on the ANNX price chart

Quiver Premium charts ANNX's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 3.85 3.87 3.73 3.80 3.80 2,022,863
Sep 23, 2026 4.18 4.19 3.81 3.87 3.87 2,423,554
Sep 22, 2026 4.28 4.34 4.13 4.18 4.18 2,000,238
Sep 21, 2026 4.27 4.36 4.12 4.22 4.22 4,187,459
Sep 18, 2026 4.16 4.31 4.13 4.23 4.23 4,940,247
Sep 17, 2026 3.92 4.22 3.92 4.17 4.17 3,119,707
Sep 16, 2026 3.91 4.00 3.88 3.93 3.93 4,515,068
Sep 15, 2026 3.93 3.98 3.79 3.92 3.92 2,960,595
Sep 14, 2026 3.97 4.04 3.88 3.95 3.95 2,896,025
Sep 11, 2026 4.20 4.20 3.92 3.94 3.94 3,939,351
Sep 10, 2026 4.33 4.33 4.04 4.14 4.14 4,204,451
Sep 9, 2026 4.60 4.66 4.34 4.37 4.37 5,529,045
Sep 8, 2026 4.76 4.79 4.64 4.67 4.67 2,139,858
Sep 4, 2026 4.81 4.91 4.79 4.87 4.87 1,227,542
Sep 3, 2026 4.93 5.04 4.76 4.84 4.84 2,313,562
Sep 2, 2026 4.90 5.08 4.78 4.93 4.93 1,842,212
Sep 1, 2026 4.96 5.00 4.85 4.89 4.89 1,472,605
Aug 31, 2026 4.99 5.04 4.83 4.94 4.94 2,436,868
Aug 28, 2026 5.18 5.21 4.95 4.97 4.97 1,618,594
Aug 27, 2026 5.00 5.32 4.91 5.25 5.25 3,024,099
Aug 26, 2026 5.13 5.17 4.96 4.99 4.99 2,276,561
Aug 25, 2026 5.13 5.22 5.08 5.15 5.15 2,941,791
Aug 24, 2026 5.05 5.13 4.80 5.06 5.06 3,378,232
Aug 21, 2026 5.24 5.28 5.02 5.07 5.07 1,430,254
Aug 20, 2026 5.41 5.46 5.11 5.18 5.18 1,670,076
Aug 19, 2026 5.45 5.59 5.34 5.50 5.50 3,504,308
Aug 18, 2026 5.03 5.31 5.02 5.28 5.28 2,244,310
Aug 17, 2026 5.26 5.29 5.06 5.13 5.13 3,625,359
Aug 14, 2026 5.21 5.34 5.08 5.29 5.29 2,990,327
Aug 13, 2026 5.36 5.40 5.20 5.26 5.26 3,122,829
Aug 12, 2026 5.06 5.42 5.00 5.33 5.33 3,950,406
Aug 11, 2026 5.40 5.45 5.17 5.34 5.34 924,795
Aug 10, 2026 5.39 5.50 5.26 5.39 5.39 1,960,169
Aug 7, 2026 5.63 5.70 5.39 5.41 5.41 2,045,960
Aug 6, 2026 5.37 5.60 5.37 5.60 5.60 3,049,250
Aug 5, 2026 5.40 5.43 5.26 5.37 5.37 1,770,792
Aug 4, 2026 5.35 5.48 5.25 5.33 5.33 2,561,996
Aug 3, 2026 5.07 5.27 4.89 5.25 5.25 2,691,798
Jul 31, 2026 5.37 5.40 5.03 5.09 5.09 2,800,727
Jul 30, 2026 4.88 5.29 4.83 5.27 5.27 2,612,790
Jul 29, 2026 4.97 5.03 4.76 4.86 4.86 3,464,094
Jul 28, 2026 5.12 5.20 4.90 4.97 4.97 2,495,623
Jul 27, 2026 5.30 5.40 5.13 5.13 5.13 1,634,974
Jul 24, 2026 5.43 5.61 5.16 5.22 5.22 2,733,766
Jul 23, 2026 5.12 5.34 5.06 5.30 5.30 2,194,269
Jul 22, 2026 5.28 5.37 5.15 5.23 5.23 1,619,854
Jul 21, 2026 5.39 5.64 4.96 5.39 5.39 2,956,278
Jul 20, 2026 5.78 5.92 5.54 5.57 5.57 2,216,349
Jul 17, 2026 5.75 6.16 5.68 5.80 5.80 3,341,464
Jul 16, 2026 6.50 6.58 5.78 5.89 5.89 7,711,289
Jul 15, 2026 5.87 6.51 5.48 6.50 6.50 8,846,423
Jul 14, 2026 5.67 5.79 5.41 5.55 5.55 5,555,931
Jul 13, 2026 5.69 5.84 5.50 5.63 5.63 3,040,205
Jul 10, 2026 5.90 5.90 5.49 5.80 5.80 2,736,861
Jul 9, 2026 5.88 6.01 5.83 5.94 5.94 4,836,228
Jul 8, 2026 6.35 6.51 5.83 5.96 5.96 7,548,993
Jul 7, 2026 5.99 6.47 5.83 6.43 6.43 5,759,444
Jul 6, 2026 5.43 6.09 5.39 5.96 5.96 6,778,989
Jul 2, 2026 5.58 5.64 5.28 5.46 5.46 2,561,838
Jul 1, 2026 5.71 6.04 5.43 5.55 5.55 4,919,969
Jun 30, 2026 5.57 5.73 5.47 5.71 5.71 3,633,748
Jun 29, 2026 5.48 5.65 5.42 5.57 5.57 8,568,150
Jun 26, 2026 5.17 5.51 5.16 5.48 5.48 14,807,062
Jun 25, 2026 5.35 5.55 5.05 5.15 5.15 3,831,642
Jun 24, 2026 5.30 5.60 5.25 5.30 5.30 3,303,484
Jun 23, 2026 4.99 5.39 4.95 5.28 5.28 5,852,080
Jun 22, 2026 4.99 5.17 4.93 5.04 5.04 3,039,599
Jun 18, 2026 5.10 5.21 4.82 4.90 4.90 7,342,604
Jun 17, 2026 4.54 4.96 4.54 4.94 4.94 2,376,526
Jun 16, 2026 4.64 4.72 4.46 4.52 4.52 2,409,029
Jun 15, 2026 4.80 4.94 4.47 4.64 4.64 2,898,247
Jun 12, 2026 4.70 4.83 4.59 4.71 4.71 3,196,199
Jun 11, 2026 4.74 4.91 4.66 4.70 4.70 1,673,915
Jun 10, 2026 5.15 5.30 4.67 4.72 4.72 2,627,039
Jun 9, 2026 5.19 5.34 5.02 5.20 5.20 3,194,947
Jun 8, 2026 5.39 5.46 5.11 5.12 5.12 3,315,505
Jun 5, 2026 5.41 5.47 5.25 5.29 5.29 1,762,568
Jun 4, 2026 5.39 5.69 5.32 5.45 5.45 3,229,767
Jun 3, 2026 5.25 5.44 5.20 5.39 5.39 2,922,034
Jun 2, 2026 5.47 5.47 5.21 5.26 5.26 2,105,072
Jun 1, 2026 5.92 5.92 5.39 5.58 5.58 4,731,711
May 29, 2026 5.37 5.48 5.24 5.42 5.42 2,176,782
May 28, 2026 5.37 5.50 5.27 5.37 5.37 2,720,612
May 27, 2026 5.55 5.64 5.38 5.39 5.39 1,931,017
May 26, 2026 5.41 5.54 5.29 5.52 5.52 4,504,765
May 22, 2026 5.45 5.57 5.25 5.31 5.31 2,180,186
May 21, 2026 4.94 5.46 4.88 5.44 5.44 3,012,143
May 20, 2026 4.97 5.10 4.93 5.04 5.04 1,808,614
May 19, 2026 4.95 5.00 4.83 4.91 4.91 2,576,200
May 18, 2026 5.20 5.35 4.91 4.96 4.96 3,279,859
May 15, 2026 5.25 5.37 5.06 5.21 5.21 1,850,635
May 14, 2026 5.45 5.53 5.33 5.37 5.37 1,588,011
May 13, 2026 5.47 5.58 5.34 5.45 5.45 2,253,576
May 12, 2026 5.62 5.62 5.44 5.44 5.44 1,189,659
May 11, 2026 5.78 5.92 5.58 5.68 5.68 2,275,203
May 8, 2026 5.62 6.03 5.56 5.69 5.69 2,011,729
May 7, 2026 5.68 5.71 5.28 5.52 5.52 2,357,572
May 6, 2026 5.80 5.82 5.65 5.70 5.70 1,351,458
May 5, 2026 5.78 5.88 5.63 5.72 5.72 1,917,644
May 4, 2026 5.68 5.92 5.62 5.69 5.69 2,335,682
May 1, 2026 5.85 5.96 5.72 5.75 5.75 1,233,969
Apr 30, 2026 5.93 6.00 5.83 5.87 5.87 2,174,817
Apr 29, 2026 5.98 6.07 5.78 5.89 5.89 2,572,013
Apr 28, 2026 6.03 6.26 5.95 6.00 6.00 2,164,086
Apr 27, 2026 5.82 6.17 5.82 6.10 6.10 3,090,492
Apr 24, 2026 6.06 6.11 5.81 5.88 5.88 1,393,813
Apr 23, 2026 6.19 6.42 6.05 6.06 6.06 2,087,383
Apr 22, 2026 6.31 6.32 6.13 6.26 6.26 1,848,202
Apr 21, 2026 6.39 6.39 6.11 6.20 6.20 1,695,151
Apr 20, 2026 6.48 6.53 6.24 6.43 6.43 1,429,294
Apr 17, 2026 6.41 6.62 6.35 6.54 6.54 3,001,191
Apr 16, 2026 6.27 6.38 6.10 6.33 6.33 2,413,689
Apr 15, 2026 5.93 6.43 5.91 6.35 6.35 4,342,086
Apr 14, 2026 5.86 5.95 5.75 5.80 5.80 2,146,586
Apr 13, 2026 5.87 6.08 5.79 5.81 5.81 1,509,788
Apr 10, 2026 6.20 6.21 5.72 5.85 5.85 2,146,122
Apr 9, 2026 5.99 6.20 5.99 6.14 6.14 1,280,705
Apr 8, 2026 6.24 6.37 5.99 6.05 6.05 2,468,282
Apr 7, 2026 5.69 6.01 5.46 5.99 5.99 2,247,279
Apr 6, 2026 5.50 5.93 5.46 5.80 5.80 3,338,034
Apr 2, 2026 5.25 5.65 5.13 5.50 5.50 3,331,285
Apr 1, 2026 5.68 5.99 5.35 5.36 5.36 2,451,572
Mar 31, 2026 5.64 6.10 5.24 5.54 5.54 4,932,583
Mar 30, 2026 5.01 5.14 4.86 4.96 4.96 2,294,244
Mar 27, 2026 5.19 5.32 5.00 5.00 5.00 1,751,838
Mar 26, 2026 5.23 5.33 5.01 5.25 5.25 2,851,124
Mar 25, 2026 5.12 5.52 5.09 5.37 5.37 2,173,578
Mar 24, 2026 5.25 5.30 4.95 5.00 5.00 2,714,799
Mar 23, 2026 5.11 5.48 5.11 5.37 5.37 2,008,027
Mar 20, 2026 5.45 5.62 5.06 5.11 5.11 10,013,180
Mar 19, 2026 5.39 5.62 5.30 5.49 5.49 2,741,087
Mar 18, 2026 5.63 5.68 5.38 5.42 5.42 2,807,943
Mar 17, 2026 5.71 5.79 5.57 5.61 5.61 1,887,574
Mar 16, 2026 5.76 5.94 5.62 5.72 5.72 3,419,498
Mar 13, 2026 5.62 5.88 5.58 5.66 5.66 1,598,433
Mar 12, 2026 5.77 5.95 5.42 5.44 5.44 2,463,170
Mar 11, 2026 6.08 6.29 5.88 6.03 6.03 1,338,872
Mar 10, 2026 5.67 6.20 5.67 6.08 6.08 2,222,592
Mar 9, 2026 5.02 5.63 5.02 5.59 5.59 2,107,270
Mar 6, 2026 5.26 5.38 5.01 5.16 5.16 1,792,674
Mar 5, 2026 5.48 5.59 5.37 5.43 5.43 3,159,346
Mar 4, 2026 5.46 5.64 5.37 5.59 5.59 3,264,034
Mar 3, 2026 5.29 5.54 5.12 5.43 5.43 6,163,870
Mar 2, 2026 5.57 5.73 5.32 5.52 5.52 3,068,823
Feb 27, 2026 5.31 5.63 5.25 5.60 5.60 4,704,230
Feb 26, 2026 5.12 5.43 4.96 5.38 5.38 4,159,393
Feb 25, 2026 5.03 5.21 4.97 5.09 5.09 2,837,215
Feb 24, 2026 4.93 5.06 4.89 4.96 4.96 2,674,698
Feb 23, 2026 4.89 5.08 4.78 4.89 4.89 1,597,695
Feb 20, 2026 5.05 5.11 4.86 4.90 4.90 1,749,101
Feb 19, 2026 5.15 5.19 5.00 5.10 5.10 1,406,317
Feb 18, 2026 4.98 5.18 4.92 5.06 5.06 1,858,213
Feb 17, 2026 4.89 5.11 4.79 5.04 5.04 2,090,401
Feb 13, 2026 5.22 5.37 4.87 4.89 4.89 1,903,991
Feb 12, 2026 5.25 5.43 5.13 5.19 5.19 2,216,032
Feb 11, 2026 5.66 5.75 5.09 5.24 5.24 2,488,978
Feb 10, 2026 5.70 5.79 5.57 5.61 5.61 3,347,432
Feb 9, 2026 5.71 5.71 5.46 5.63 5.63 1,716,658
Feb 6, 2026 5.79 5.86 5.58 5.73 5.73 2,060,577
Feb 5, 2026 5.93 6.21 5.43 5.63 5.63 2,384,619
Feb 4, 2026 6.42 6.52 5.90 6.04 6.04 1,884,601
Feb 3, 2026 6.36 6.59 6.30 6.48 6.48 1,435,503
Feb 2, 2026 6.13 6.55 6.10 6.38 6.38 1,572,041
Jan 30, 2026 6.65 6.84 6.16 6.24 6.24 1,841,321
Jan 29, 2026 6.41 6.55 6.30 6.52 6.52 1,287,889
Jan 28, 2026 6.63 6.63 6.26 6.29 6.29 3,741,702
Jan 27, 2026 6.66 6.82 6.49 6.57 6.57 2,449,810
Jan 26, 2026 6.70 6.75 6.42 6.66 6.66 1,714,446
Jan 23, 2026 6.98 7.18 6.75 6.78 6.78 2,337,070
Jan 22, 2026 6.87 7.06 6.86 6.96 6.96 2,780,332
Jan 21, 2026 6.17 6.88 6.17 6.85 6.85 2,997,429
Jan 20, 2026 6.06 6.19 5.85 6.16 6.16 1,949,797
Jan 16, 2026 6.20 6.28 6.05 6.07 6.07 1,616,892
Jan 15, 2026 6.69 6.75 6.15 6.16 6.16 2,970,185
Jan 14, 2026 6.20 6.83 6.00 6.68 6.68 4,643,926
Jan 13, 2026 5.53 6.30 5.50 6.19 6.19 2,793,922
Jan 12, 2026 5.25 5.57 5.12 5.56 5.56 1,816,350
Jan 9, 2026 5.38 5.54 5.22 5.25 5.25 1,870,725
Jan 8, 2026 5.52 5.54 5.25 5.29 5.29 2,428,721
Jan 7, 2026 5.10 5.73 5.10 5.53 5.53 3,142,227
Jan 6, 2026 5.17 5.17 4.95 5.10 5.10 3,203,744
Jan 5, 2026 4.74 5.23 4.54 5.22 5.22 5,408,612
Jan 2, 2026 5.10 5.16 4.65 4.69 4.69 2,102,617
Dec 31, 2025 5.04 5.12 4.95 5.02 5.02 2,107,909
Dec 30, 2025 5.02 5.18 4.95 5.04 5.04 1,934,723
Dec 29, 2025 5.04 5.18 4.99 5.00 5.00 1,355,691
Dec 26, 2025 5.16 5.27 4.94 5.11 5.11 1,670,270
Dec 24, 2025 5.15 5.29 5.11 5.18 5.18 955,878
Dec 23, 2025 5.32 5.32 5.04 5.11 5.11 2,169,793
Dec 22, 2025 5.18 5.48 5.11 5.19 5.19 2,401,978
Dec 19, 2025 4.86 5.42 4.85 5.17 5.17 10,460,487
Dec 18, 2025 4.99 5.11 4.80 4.82 4.82 2,705,162
Dec 17, 2025 4.82 4.97 4.80 4.90 4.90 1,810,596
Dec 16, 2025 4.91 5.01 4.75 4.80 4.80 2,618,717
Dec 15, 2025 4.99 5.07 4.79 4.91 4.91 3,344,242
Dec 12, 2025 5.03 5.34 4.95 4.97 4.97 5,562,697
Dec 11, 2025 4.91 5.12 4.88 5.04 5.04 3,393,146
Dec 10, 2025 4.85 5.00 4.84 4.90 4.90 1,666,824
Dec 9, 2025 4.87 4.98 4.79 4.86 4.86 2,274,952
Dec 8, 2025 4.72 5.00 4.71 4.86 4.86 2,433,500
Dec 5, 2025 4.48 4.74 4.48 4.61 4.61 1,944,309
Dec 4, 2025 4.45 4.54 4.25 4.49 4.49 2,489,315
Dec 3, 2025 4.10 4.31 4.08 4.28 4.28 1,777,202
Dec 2, 2025 4.26 4.44 4.01 4.06 4.06 4,167,576
Dec 1, 2025 4.42 4.50 4.07 4.13 4.13 2,248,232
Nov 28, 2025 4.36 4.64 4.35 4.50 4.50 1,763,963
Nov 26, 2025 4.41 4.45 4.26 4.32 4.32 3,045,876
Nov 25, 2025 4.53 4.60 4.33 4.44 4.44 2,852,670
Nov 24, 2025 4.45 4.70 4.37 4.51 4.51 3,844,244
Nov 21, 2025 4.29 4.42 4.17 4.27 4.27 3,979,106
Nov 20, 2025 4.40 5.07 4.25 4.27 4.27 8,299,930
Nov 19, 2025 3.58 4.20 3.50 4.06 4.06 10,650,536
Nov 18, 2025 3.02 3.29 2.99 3.20 3.20 2,951,950
Nov 17, 2025 2.69 3.12 2.67 3.02 3.02 3,647,775
Nov 14, 2025 2.68 2.90 2.65 2.71 2.71 3,507,836
Nov 13, 2025 2.57 2.83 2.54 2.68 2.68 3,853,220
Nov 12, 2025 2.96 2.97 2.74 2.84 2.84 1,922,271
Nov 11, 2025 2.95 3.03 2.86 2.97 2.97 935,534
Nov 10, 2025 2.92 3.01 2.90 2.98 2.98 837,391
Nov 7, 2025 2.98 2.98 2.65 2.88 2.88 1,639,126
Nov 6, 2025 3.08 3.12 2.92 3.02 3.02 1,052,476
Nov 5, 2025 3.08 3.15 2.98 3.01 3.01 1,421,224
Nov 4, 2025 3.05 3.16 3.02 3.08 3.08 1,884,178
Nov 3, 2025 3.20 3.37 3.09 3.17 3.17 2,370,793
Oct 31, 2025 2.93 3.23 2.89 3.16 3.16 3,738,058
Oct 30, 2025 3.16 3.20 2.91 2.93 2.93 1,726,165
Oct 29, 2025 3.45 3.50 3.17 3.19 3.19 2,946,904
Oct 28, 2025 3.52 3.60 3.43 3.45 3.45 1,716,670
Oct 27, 2025 3.26 3.55 3.26 3.54 3.54 1,970,080
Oct 24, 2025 3.06 3.34 3.06 3.21 3.21 3,194,589
Oct 23, 2025 2.99 3.06 2.90 3.05 3.05 1,222,934
Oct 22, 2025 3.13 3.15 2.88 3.00 3.00 1,691,050
Oct 21, 2025 3.17 3.22 3.05 3.13 3.13 1,663,711
Oct 20, 2025 3.23 3.29 3.12 3.16 3.16 2,246,102
Oct 17, 2025 3.14 3.35 3.09 3.15 3.15 1,554,756
Oct 16, 2025 3.08 3.26 3.05 3.17 3.17 1,618,548
Oct 15, 2025 3.00 3.21 2.95 3.04 3.04 1,731,946
Oct 14, 2025 2.93 3.05 2.86 3.00 3.00 1,573,718
Oct 13, 2025 3.12 3.18 2.92 3.00 3.00 1,147,894
Oct 10, 2025 3.26 3.26 2.93 3.10 3.10 2,175,849
Oct 9, 2025 3.15 3.30 3.09 3.26 3.26 1,593,096
Oct 8, 2025 3.07 3.22 3.04 3.15 3.15 1,611,185
Oct 7, 2025 3.19 3.23 3.06 3.07 3.07 917,956
Oct 6, 2025 3.22 3.29 3.15 3.18 3.18 1,119,162
Oct 3, 2025 3.19 3.38 3.11 3.19 3.19 1,518,164
Oct 2, 2025 3.04 3.16 3.00 3.11 3.11 3,010,713
Oct 1, 2025 3.02 3.18 2.98 3.03 3.03 1,406,779
Sep 30, 2025 3.08 3.14 2.91 3.05 3.05 2,944,985
Sep 29, 2025 3.38 3.42 3.02 3.12 3.12 5,535,864
Sep 26, 2025 2.81 3.41 2.77 3.37 3.37 5,462,355
Sep 25, 2025 2.78 2.88 2.75 2.79 2.79 1,346,042
Sep 24, 2025 2.92 2.98 2.79 2.82 2.82 1,911,026

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Annexon, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ANNX, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation